Atlas Trials

Fibroblast Growth Factor 23 and Risk of Cardiac Arrhythmias in Hemodialysis Patients

Clinical trial NCT06668831 · RECRUITING

Trial details

NCT number
NCT06668831
Sponsor
Antonio Bellasi
Status
RECRUITING
Study type
OBSERVATIONAL
Hemodialysis
Start date
2024-10-12
Primary completion
2025-10-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.